New research out of McGill University's Goodman Cancer Research Centre provides compelling new evidence that a gene known as 14-3-3ó plays a critical role in halting breast cancer initiation and progression. The study, led by the Dept. of Biochemistry's William J. Muller, will be published online today in the journal Cancer Discovery.
The discovery of this new target points to novel therapies that eventually could slow or stop breast cancer progression. Muller also says that this gene is likely a major player in a number of other types of cancer.
Based on past clinical observations revealing that the expression of gene 14-3-3ó is silenced in a large percentage of breast cancers, researchers had long suspected that it played a role in stopping cancer cells from dividing. The McGill team wanted to confirm whether this was the case. Using a transgenic mouse model that expresses ErbB2, an oncogene associated with aggressive breast cancers, they inactivated the 14-3-3ó gene in the mammary gland.
"We found that the loss of this expression did, in fact, result in a dramatic acceleration of tumour onset," explained Muller who is also affiliated with the Research Institute of the McGill University Health Centre (RI MUHC). "The two genes, 14-3-3ó and ErbB2, co-operate, with 14-3-3ó being the brakes. If you lose the brakes, ErbB2 can induce the cells to divide indefinitely. Furthermore, not only is the ability of these cells to divide enhanced but they become extraordinarily metastatic. They can invade distant sites."
Co-authors include Chen Ling, Vi-Minh-Tri Su and Dongmei Zuo. All are from the Goodman Cancer Research Centre and McGill's Faculty of Medicine in the Dept. of Biochemistry. All authors were supported by grants from the Canadian Institutes of Health Research (CIHR) and the Terry Fox Foundation.
"We are pleased that our funding has led to a better understanding of molecular mechanisms of breast cancer development, which ultimately will lead to improved interventions for breast cancer patients " said Dr. Morag Park, the Scientific Director of the CIHR, Institute of Cancer.
The paper, Loss of the 14-3-3ó tumour suppressor is a critical event in ErbB2-mediated tumour progression, may be found here: http://cancerdiscovery.aacrjournals.org/content/early/2011/11/10/2159-8290.CD-11-0189.abstract
Allison Flynn | EurekAlert!
One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie
The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy